By Tim Fitzgerald A patent confers a limited-term right to exclude other parties from using an invention, in exchange for a comprehensive description of the invention. The granted claims of a patent define the scope of the right that is conferred. Patents are jurisdiction-specific – a patent granted in one jurisdiction does not (at least […]
Read MoreBy Tim Fitzgerald* and Michael Finney** — ‘Swiss format’ or ‘Swiss-type’ patent claims have a general structure similar to the following: Use of compound X in the manufacture of a formulation for the treatment of medical condition Y. Swiss-type claims were originally approved by the Swiss Patent Office as a mechanism to allow for protection […]
Read MoreAIPPI conference in London 14-18 September 2019 Wayne Slater will be attending the upcoming AIPPI conference in London on behalf of our firm. Wayne is a member of the AIPPI standing committee on designs and will also be taking the opportunity to meet the UK clients of the firm. This year the world Congress for […]
Read More
The annual BIO International Convention for 2019 will be held at the Pennsylvania Convention Center, Philadelphia . The delegates will gather together for unique opportunities for education and networking with some of the global leaders in biotech, pharma and life science. IP Gateway is emerging as a leading Australian firm for patent matters in the life […]
Read More
OPIUM WARS By Alison McMillan PhD The Tasmanian licit opium poppy industry provides about 50% of the world’s Narcotic Raw Material (NRM). The industry is worth about $290 million to Tasmania. The Tasmanian poppy industry is controlled by three companies, SunPharma, India’s largest pharmaceutical company, Tasmanian Alkaloids Pty Ltd (Tas Alkaloids) owned by SK […]
Read More